---
schema_version: "secwatch.filing_event.v1"
accession: "0001410578-25-002072"
form_type: "8-K"
ticker: "CYPH"
cik: "0001509745"
company_name: "CYPHERPUNK TECHNOLOGIES INC."
filed_at: "2025-09-11T23:59:59+00:00"
generated_at: "2026-05-17T06:52:24.213265+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Leap Therapeutics gets Nasdaq bid price extension to March 9, 2026

## Summary
- Nasdaq granted additional 180-day compliance period until March 9, 2026, for minimum $1.00 bid price.
- Initial 180-day period ended Sept. 8, 2025; company met all other listing standards except bid price.
- Company may implement a reverse stock split to regain compliance.
- No assurance of regaining compliance; delisting could follow if not cured by March 9, 2026.

## SEC filing metadata
- accession: 0001410578-25-002072
- form_type: 8-K
- ticker: CYPH
- cik: 0001509745
- company_name: CYPHERPUNK TECHNOLOGIES INC.
- filed_at: 2025-09-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509745/000141057825002072/0001410578-25-002072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509745/000141057825002072/tm2525891d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001410578-25-002072
- JSON: https://secwatch.observer/filing/0001410578-25-002072.json
- Plain text: https://secwatch.observer/filing/0001410578-25-002072.txt

## Key facts
- Listing & Compliance Notices
  CYPHERPUNK TECHNOLOGIES INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: September 8, 2025, to regain compliance with Rule 5550(a)(2) by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. Additionally, Nasdaq notified the Company that it might be eligible for an additional compliance period of 180 calendar days if, on September 8, 2025, the Company met the continued listing requirement for market value of publicly held shares and all other applicable standards for initial listing on the Nasdaq Capital Market (with the exception of the closing bid price requirement) based on the Company’s then most recent publi
  evidence_url: https://www.sec.gov/Archives/edgar/data/1509745/000141057825002072/0001410578-25-002072-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.